The issue of statin safety - Where do we stand?

被引：72

作者：

Grundy, SM

机构：

[1] Univ Texas, SW Med Ctr, Ctr Human Nutr, Dallas, TX 75390 USA

[2] Univ Texas, SW Med Ctr, Dept Clin Nutr, Dallas, TX 75390 USA

[3] Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA

来源：

CIRCULATION | 2005年 / 111卷 / 23期

关键词：

editorials; statins; safety; adverse effects;

D O I：

10.1161/CIRCULATIONAHA.105.557652

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：3016 / 3019

页数：4

共 11 条

[1] The safety of rosuvastatin as used in common clinical practice - A postmarketing analysis [J].

Alsheikh-Ali, AA ;

Ambrose, MS ;

Kuvin, JT ;

Karas, RH .

CIRCULATION, 2005, 111 (23) :3051-3057

[2]

Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3

[3]

*DEP HHS, 2003, FOOD DRUG ADM CTR DR

[4] Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report [J].

Grundy, SM ;

Becker, D ;

Clark, LT ;

Cooper, RS ;

Denke, MA ;

Howard, WJ ;

Hunninghake, DB ;

Illingworth, R ;

Luepker, RV ;

McBride, P ;

McKenney, JM ;

Pasternak, RC ;

Stone, NJ ;

Van Horn, L ;

Brewer, HB ;

Cleeman, JI ;

Ernst, ND ;

Gordon, D ;

Levy, D ;

Rifkind, B ;

Rossouw, JE ;

Savage, P ;

Haffner, SM ;

Orloff, DG ;

Proschan, MA ;

Schwartz, JS ;

Sempos, CT ;

Shero, ST ;

Murray, EZ ;

Keller, SA ;

Jehle, AJ .

CIRCULATION, 2002, 106 (25) :3143-3421

[5] Alternative approaches to cholesterolin lowering therapy [J].

Grundy, SM .

AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (10) :1135-+

[6] Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines [J].

Grundy, SM ;

Cleeman, JI ;

Merz, CNB ;

Brewer, HB ;

Clark, LT ;

Hunninghake, DB ;

Pasternak, RC ;

Smith, SC ;

Stone, NJ .

CIRCULATION, 2004, 110 (02) :227-239

[7] Intensive lipid lowering with atorvastatin in patients with stable coronary disease [J].

LaRosa, JC ;

Grundy, SM ;

Waters, DD ;

Shear, C ;

Barter, P ;

Fruchart, J ;

Gotto, AM ;

Greten, H ;

Kastelein, JJP ;

Shepherd, J ;

Wenger, NK .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (14) :1425-1435

[8] FDA adverse event reports on statin-associated rhabdomyolysis [J].

Omar, MA ;

Wilson, JP .

ANNALS OF PHARMACOTHERAPY, 2002, 36 (02) :288-295

[9] ACC/AHA/NHLBI clinical advisory on the use and safety of statins [J].

Pasternak, RC ;

Smith, SC ;

Bairey-Merz, CN ;

Grundy, SM ;

Cleeman, JI ;

Lenfant, C .

CIRCULATION, 2002, 106 (08) :1024-1028

[10] Safety of rosuvastatin [J].

Shepherd, J ;

Hunninghake, DB ;

Stein, EA ;

Kastelein, JJP ;

Harris, S ;

Pears, J ;

Hutchinson, HG .

AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (07) :882-888

← 1 2 →